WallStreetZenWallStreetZen

NYSEMKT: NNVC
Nanoviricides Inc Stock Ownership - Who owns Nanoviricides?

Insider buying vs selling

Have Nanoviricides Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NNVC insiders and whales buy or sell their stock.

NNVC Shareholders

What type of owners hold Nanoviricides Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Theracour Pharma Inc282.05%33,321,000$100.96MInsider
Milton Boniuk128.32%15,159,145$45.93MInsider
Anil Diwan17.31%2,044,918$6.20MInsider
Eugene Seymour10.57%1,248,814$3.78MInsider
Vanguard Group Inc3.88%458,416$1.39MInstitution
Meeta Vyas3.72%439,570$1.33MInsider
Blackrock Inc1.34%158,752$481.02kInstitution
Compagnie Lombard Odier Scma1.27%150,000$454.50kInstitution
Geode Capital Management LLC0.93%109,489$331.75kInstitution
Renaissance Technologies LLC0.72%84,500$256.04kInstitution

1 of 3

NNVC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NNVC2.23%97.77%
FBIO14.72%60.54%Net BuyingNet Buying
LEXX6.90%4.82%Net BuyingNet Buying
NXTC53.54%46.46%
MTNB10.15%11.91%

Nanoviricides Stock Ownership FAQ

Who owns Nanoviricides?

Nanoviricides (NYSEMKT: NNVC) is owned by 10.10% institutional shareholders, 441.96% Nanoviricides insiders, and 0.00% retail investors. Theracour Pharma Inc is the largest individual Nanoviricides shareholder, owning 33.32M shares representing 282.05% of the company. Theracour Pharma Inc's Nanoviricides shares are currently valued at $110.29M.

If you're new to stock investing, here's how to buy Nanoviricides stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.